Live Breaking News & Updates on Dean Of Tufts University School Medicine

Stay updated with breaking news from Dean of tufts university school medicine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

MGH: 'Unprecedented pediatric surge' of RSV

Pediatric ICUs are bursting at the seams as physicians face an unusually early and severe season of respiratory syncytial virus, also known as RSV. ....

United States , Tufts University , Helen Boucher , Alexy Arauz Boudreau , Brian Cummings , Paul Biddinger , Centers For Disease , Dean Of Tufts University School Medicine , General Hospital , Mass General Brigham , General Brigham , Disease Control , Tufts University School , Brian Cummings , Mass General Hospital ,

Massachusetts will stop daily COVID case count report, switch to weekly

Starting next week, the Massachusetts Department of Public Health will release coronavirus case numbers every Thursday. ....

Tufts University , United States , Helen Boucher , Catherine Brown , Massachusetts Department Of Public Health , Dean Of Tufts University School Medicine , Massachusetts Department , Public Health , State Epidemiologist , Interim Dean , Tufts University School , Chief Academic Officer , Tufts Medicine , Medical Advisory , Interactive Data Dashboard , Contact Tracing ,

PYC Therapeutics Appoints U.S. Biotech Veteran Michael Rosenblatt, MD, to its Board of Directors

Share this article
Share this article
NEW YORK and PERTH, Australia, March 17, 2021 /PRNewswire/ PYC Therapeutics (ASX: PYC), a biotechnology company developing a new generation of precision RNA therapeutics to change the lives of patients with inherited diseases, today announced the appointment of Michael Rosenblatt, MD, to its Board of Directors. Dr. Rosenblatt is a Senior Partner at Flagship Pioneering, a leading-edge innovation organization that conceives, creates and develops first-in-category life science companies, and the former Chief Medical Officer of Merck, one of the world s leading global biopharmaceutical companies.
Dr. Rosenblatt brings over four decades of visionary leadership experience across biopharmaceutical companies and academic institutions, and as a practicing physician. In his current role at Flagship, he has helped launch several renowned biotechnology companies in the Flagship ecosystem, including providing counsel on clinical development ....

Tufts University , United States , Western Australia , Ohana Biosciences , Michael Rosenblatt , Sahm Nasseri , Roberth Ebert , Georger Minot , Vaccine Acceleration Committee , Harvard Medical School , Radius Pharmaceuticals , Columbia University , Human Genome Sciences , Moderna Therapeutic Development Committee Of The Board , Division Of Health Sciences , Dean Of Tufts University School Medicine , Senior Partner , Flagship Pioneering , Chief Medical Officer , Rubius Therapeutics , Cygnal Therapeutics , Moderna Therapeutic Development Committee , Executive Officer , Executive Vice President , Tufts University School , Molecular Medicine ,